产品名称

BMS 204352, (±)-

产品货号

Axon 1308 CAS [183720-28-7] MF C16H10ClF4NO2MW 359.70 Purity: 98% Soluble in DMSO Description Potassium channel opener; racemate of more active S-(+)-enantiomer, BMS-204352 (Flindokalner, Axon 1112), and less active R-(-)-enantiomer (Axon 1309) References Certificates Categories Extra info Krishna R et al. Pharmacokinetics and dose proportionality of BMS-204352 after intraarterial administration to rats. Biopharm Drug Dispos. 2002, 23(6), 233-7. M. P. G. Korsgaard et al. Anxiolytic Effects of Maxipost (BMS-204352) and Retigabine via Activation of Neuronal Kv7 Channels. J. Pharmacol. Exp. Ther. 2005, 314, 282-292. Certificate of Analysis Material Safety Data Sheet Cardiovascular CNS KCa1.1 KCNMA1 Potassium channel opener; racemate of Axon 1112 Chemical name 3-(5-Chloro-2-methoxy-phenyl)-3-fluoro-6-trifluoromethyl-1,3-dihydro-indol-2-one Parent CAS No. [183720-28-7] Inquire

产品价格

现货询价，电话：010-67529703

产品规格

产品品牌

axonmedchem

产品概述

产品详情

BMS 204352, (±)-

Based on 12 reference(s) in Google Scholar 9 10 12

Axon 1308

CAS [183720-28-7]

MF C16H10ClF4NO2
MW 359.70

Purity: 98%
Soluble in DMSO

BMS 204352, (±)-

Description

Potassium channel opener; racemate of more active S-(+)-enantiomer, BMS-204352 (Flindokalner, Axon 1112), and less active R-(-)-enantiomer (Axon 1309)

Krishna R et al. Pharmacokinetics and dose proportionality of BMS-204352 after intraarterial administration to rats. Biopharm Drug Dispos. 2002, 23(6), 233-7.

M. P. G. Korsgaard et al. Anxiolytic Effects of Maxipost (BMS-204352) and Retigabine via Activation of Neuronal Kv7 Channels. J. Pharmacol. Exp. Ther. 2005, 314, 282-292.

Potassium channel opener; racemate of Axon 1112

Chemical name

3-(5-Chloro-2-methoxy-phenyl)-3-fluoro-6-trifluoromethyl-1,3-dihydro-indol-2-one

Parent CAS No.

[183720-28-7]

产品资料